Akèy › Sindwòm entesten iritab › Arizona
Etid klinik pou Sindwòm entesten iritab nan Arizona
3 etid pou Sindwòm entesten iritab ap chèche patisipan nan sit nan Arizona.
Tèks ofisyèl etid la (Anglè)
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
- GSK Investigational Site, Phoenix
- GSK Investigational Site, Scottsdale
- GSK Investigational Site, Tempe
- ak 1 plis
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07519395A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)
- Del Sol Research Management - Mesa, Mesa
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 22, 2026 · NCT07545772A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)
- Del Sol Research Management - Mesa, Mesa
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 22, 2026 · NCT07545759Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.